0001213900-22-010596.txt : 20220303 0001213900-22-010596.hdr.sgml : 20220303 20220303164116 ACCESSION NUMBER: 0001213900-22-010596 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20220303 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20220303 DATE AS OF CHANGE: 20220303 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Vicarious Surgical Inc. CENTRAL INDEX KEY: 0001812173 STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-39384 FILM NUMBER: 22709617 BUSINESS ADDRESS: STREET 1: 78 FOURTH AVENUE CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: (617) 868-1700 MAIL ADDRESS: STREET 1: 78 FOURTH AVENUE CITY: WALTHAM STATE: MA ZIP: 02451 FORMER COMPANY: FORMER CONFORMED NAME: D8 Holdings Corp. DATE OF NAME CHANGE: 20200514 8-K 1 ea156428-8k_vicarious.htm FORM 8-K
0001812173 false 0001812173 2022-03-03 2022-03-03 0001812173 RBOT:ClassCommonStockParValue0.0001PerShareMember 2022-03-03 2022-03-03 0001812173 RBOT:WarrantsToPurchaseOneShareOfClassCommonStockEachAtExercisePriceOf11.50PerShareMember 2022-03-03 2022-03-03 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of the

Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): March 3, 2022

 

VICARIOUS SURGICAL INC.

(Exact name of registrant as specified in its charter)

 

Delaware 001-39384 87-2678169
(State or other jurisdiction of incorporation) (Commission File Number)

(IRS Employer

Identification No.)

     

78 Fourth Avenue

Waltham, Massachusetts

(Address of principal executive offices)

  

 

02451

(Zip Code)

 

Registrant’s telephone number, including area code: (617) 868-1700

N/A

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class   Trading Symbol(s)   Name of each exchange on
which registered
Class A common stock, par value $0.0001 per share   RBOT   The New York Stock Exchange
Warrants to purchase one share of Class A common stock, each at an exercise price of $11.50 per share   RBOT WS   The New York Stock Exchange

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

Item 2.02. Results of Operations and Financial Condition.

On March 3, 2022, Vicarious Surgical Inc. (the “Company”) issued a press release announcing its results for the fourth quarter ended December 31, 2021 and providing a business update. A copy of the press release is furnished as Exhibit 99.1 hereto.

The information in this Current Report on Form 8-K (including Exhibit 99.1) shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.

  Item 9.01 Financial Statements and Exhibits.

 

(d) Exhibits.

 

Exhibit
No.		   Description
     
99.1   Press Release dated March 3, 2022
     
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

 

 

 SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

  VICARIOUS SURGICAL INC.
   
  By:  /s/ Adam Sachs
  Name: Adam Sachs
  Title: President and Chief Executive Officer

 Date: March 3, 2022

 

 

 EX-99.1 2 ea156428ex99-1_vicarious.htm PRESS RELEASE DATED MARCH 3, 2022

Exhibit 99.1

 

Vicarious Surgical Reports Fourth Quarter and Full Year 2021 Financial Results

 

WALTHAM, Mass.-- (BUSINESS WIRE) – March 3, 2022 – Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve patient outcomes as well as both the cost and efficiency of surgical procedures, today announced its preliminary unaudited fourth quarter and full year 2021 financial results.

 

“2021 was an incredible year at Vicarious Surgical. I want to congratulate our team and thank our investors, advisors, and partners for supporting our pathway to becoming a public company while furthering our mission and commitment to lower barriers to surgical robotics and improve patient outcomes,” said Adam Sachs, Chief Executive Officer of Vicarious Surgical. “Our progress reflects the tremendous potential of the Vicarious System and the immense opportunity ahead.”

 

In conjunction, Vicarious Surgical is providing a regulatory update. Based upon the Company’s recent pre-submission communications with the U.S. Food and Drug Administration (“FDA”) to gain alignment on the clinical and regulatory pathway for the Vicarious System, the Company intends to pursue a pre-market trial to collect human clinical data for inclusion in a De Novo classification request of the Vicarious System to the FDA for its initial indication of ventral hernia repair. Management will provide greater details regarding its intended clinical and regulatory pathway on today’s conference call (see details below).

 

Fourth Quarter 2021 Financial Results

 

  ● Operating expenses were $18.2 million for the fourth quarter of 2021, compared to $3.8 million in the corresponding prior year period, which represents an increase of 380%.

 

  ● R&D expenses for the fourth quarter of 2021 were $9.3 million, compared to $3.0 million in the fourth quarter of 2020.

 

  ● General and administrative expenses for the fourth quarter of 2021 were $7.3 million, compared to $0.7 million in the fourth quarter of 2020.

 

  ● Sales and marketing expenses for the fourth quarter of 2021 were $1.6 million, compared to $0.1 million in the fourth quarter of 2020.

 

  ● Adjusted net loss for the fourth quarter was $18.2 million, equating to a loss of $0.15 per share, as compared to a net loss of $3.8 million, or a loss of $0.04 per share, for the same period of the prior year.  GAAP Net income for the fourth quarter was $70.1 million dollars, equating to a net income per share of $0.59 per share, as compared to a net loss of $3.8 million or a loss of $0.04 per share for the same period of the prior year.

 

  ● Cash burn rate for the fourth quarter of 2021 was $11.5 million.

 

Full Year 2021 Financial Results

 

  ● Operating expenses were $38.6 million for 2021, compared to $13.0 million in the prior year, which represents an increase of 197%.

 

  ● R&D expenses for 2021 were $22.1 million, compared to $9.8 million in 2020.

 

  ● General and administrative expenses for 2021 were $13.5 million, compared to $2.3 million in 2020.

 

  ● Sales and marketing expenses for 2021 were $3.0 million, compared to $0.9 million in 2020.

 

  ● Adjusted net loss for 2021 was $38.6 million, equating to a loss of $0.33 per share, as compared to an adjusted net loss of $12.9 million, or a loss of $0.16 per share, in the prior year. GAAP Net loss for 2021 was $7.3 million dollars, equating to a net loss per share of $0.06 per share, as compared to a net loss of $12.9 million or a loss of $0.16 per share in the prior year.

 

  ● Cash and cash equivalents were $173.5 million as of December 31, 2021.

 

 

 

 

Conference Call

 

Vicarious Surgical will host a conference call at 4:30 p.m. ET on Thursday, March 3, 2021, to discuss its preliminary unaudited fourth quarter 2021 financial results. The call may be accessed through an operator by dialing + 1 (646) 904 5544 for domestic callers or + 1 (929) 526 1599 for international callers, using access code: 467032. A live and archived webcast of the event will be available at https://investor.vicarioussurgical.com.

 

About Vicarious Surgical

 

Founded in 2014, Vicarious Surgical is a next generation robotics company developing a disruptive technology with the goals of increasing the efficiency of surgical procedures, improving patient outcomes, and reducing healthcare costs. The Company’s novel surgical approach uses proprietary human-like surgical robots to transport surgeons inside the patient to perform minimally invasive surgery. The Company is led by an experienced team of technologists, medical device professionals and physicians, and is backed by technology luminaries including Bill Gates, Vinod Khosla’s Khosla Ventures, Innovation Endeavors, Jerry Yang’s AME Cloud Ventures, Sun Hung Kai & Co. Ltd and Philip Liang’s E15 VC. The Company is headquartered in Waltham, Massachusetts. Learn more at www.vicarioussurgical.com.

 

Use of Non-GAAP Financial Measures

 

In addition to providing financial measurements that have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”), Vicarious Surgical provides additional financial metrics that are not prepared in accordance with U.S. GAAP (“non-GAAP”). The non-GAAP financial measures included in this press release are Adjusted Net Loss and Adjusted Net Loss Per Share (“Adjusted EPS”, together “Non-GAAP Financial Measures”). The Company presents Non-GAAP Financial Measures in order to assist readers of its consolidated financial statements in understanding the core operating results that its management uses to evaluate the business and for financial planning purposes. Vicarious Surgical’s Non-GAAP financial measures provide an additional tool for investors to use in comparing its financial performance over multiple periods.

 

Adjusted Net Loss and Adjusted EPS are key performance measures that Vicarious Surgical’s management uses to assess its operating performance. These Non-GAAP Financial Measures facilitate internal comparisons of Vicarious Surgical’s operating performance on a more consistent basis. Vicarious Surgical uses these performance measures for business planning purposes and forecasting. Vicarious Surgical believes that the Non-GAAP Financial Measures enhance an investor’s understanding of Vicarious Surgical’s financial performance as it is useful in assessing its operating performance from period-to-period by excluding certain items that Vicarious Surgical believes are not representative of its core business.

 

The Non-GAAP Financials Measures may not be comparable to similarly titled measures of other companies because they may not calculate this measure in the same manner. Adjusted Net Loss and Adjusted EPS are not prepared in accordance with U.S. GAAP and should not be considered in isolation of, or as an alternative to, measures prepared in accordance with U.S. GAAP. When evaluating Vicarious Surgical’s performance, you should consider the Non-GAAP Financial Measures alongside other financial performance measures prepared in accordance with U.S. GAAP, including net loss.

 

The Non-GAAP Financial Measures do not replace the presentation of Vicarious Surgical’s U.S. GAAP financial results and should only be used as a supplement to, not as a substitute for, Vicarious Surgical’s financial results presented in accordance with U.S. GAAP. In this press release, Vicarious Surgical has provided a reconciliation of Adjusted Net Loss to net loss, the most directly comparable U.S. GAAP financial measure and the calculation for Adjusted EPS.

 

2

 

 

Preliminary Unaudited Results

 

In addition, our expectations regarding fourth quarter and full year 2021 results are based on preliminary unaudited information about the fourth quarter and full year and are subject to revision. Although the fourth quarter is now completed, we are still in the process of our standard financial reporting closing procedures. Accordingly, as we complete our normal quarter and year-end closing and review processes, actual results could differ materially from these preliminary results. Factors that could cause our actual results for the fourth quarter and full year 2021 to differ materially from our preliminary results include, but are not limited to, inaccurate assumptions, unrecorded expenses, changes in estimates or judgments, and facts or circumstances affecting the application of the Company’s critical accounting policies.

 

Forward-Looking Statements

 

This press release includes “forward-looking statements” within the meaning of the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995. The company’s actual results may differ from its expectations, estimates, and projections and, consequently, you should not rely on these forward-looking statements as predictions of future events. All statements other than statements of historical facts contained herein, including without limitation the quotations of our Chief Executive Officer regarding Vicarious Surgical’s opportunity, among other things, are forward-looking statements that reflect the current beliefs and expectations of management. These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from those discussed in the forward-looking statements. Most of these factors are outside Vicarious Surgical’s control and are difficult to predict. Factors that may cause such differences include, but are not limited to: the impact of COVID-19 on Vicarious Surgical’s business; changes in applicable laws or regulations; the ability of Vicarious Surgical to raise financing in the future; the success, cost and timing of Vicarious Surgical’s product and service development activities; the potential attributes and benefits of Vicarious Surgical’s products and services; Vicarious Surgical’s ability to obtain and maintain regulatory approval for the Vicarious System, and any related restrictions and limitations of any approved product; the size and duration of human clinical trials for the Vicarious Surgical; Vicarious Surgical’s ability to identify, in-license or acquire additional technology; Vicarious Surgical’s ability to maintain its existing license, manufacture, supply and distribution agreements; Vicarious Surgical’s ability to compete with other companies currently marketing or engaged in the development of products and services that Vicarious Surgical is currently marketing or developing; the size and growth potential of the markets for Vicarious Surgical’s products and services, and its ability to serve those markets, either alone or in partnership with others; the pricing of Vicarious Surgical’s products and services and reimbursement for medical procedures conducted using its products and services; the company’s estimates regarding expenses, revenue, capital requirements and needs for additional financing; Vicarious Surgical’s financial performance; and other risks and uncertainties indicated from time to time in Vicarious Surgical’s filings with the SEC. Vicarious Surgical cautions that the foregoing list of factors is not exclusive. The company cautions readers not to place undue reliance upon any forward-looking statements, which speak only as of the date made. Vicarious Surgical does not undertake or accept any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements to reflect any change in its expectations or any change in events, conditions or circumstances on which any such statement is based.

  

Investor Inquiries:

Marissa Bych

Gilmartin Group LLC

ir@vicarioussurgical.com

 

Press and Media Inquiries:

Jill Gross
Matter Communications
media@vicarioussurgical.com

 

3

 

 

VICARIOUS SURGICAL INC.
STATEMENTS OF OPERATIONS
FOR THE YEARS ENDED DECEMBER 31, 2021 AND 2020
(in thousands except, per share data)

 

   Year Ended December 31, 
   2021   2020 
Operating expenses:        
Research and development  $22,100   $9,796 
Sales and marketing   2,976    861 
General and administrative   13,498    2,328 
Total operating expenses   38,574    12,985 
Loss from operations   (38,574)   (12,985)
Other income (expense):          
Change in fair value of warrant liabilities   31,375    — 
Interest income   20    113 
Interest expense   (89)   (3)
Loss before income taxes   (7,268)   (12,875)
Provision for income taxes   —    — 
Net loss  $(7,268)  $(12,875)
Net loss per share of Class A and Class B common stock, basic and diluted  $(0.06)  $(0.16)

 

See accompanying notes to these financial statements.

 

4

 

 

VICARIOUS SURGICAL INC.
BALANCE SHEETS

AS OF DECEMBER 31, 2021 and 2020
(in thousands, except share and per share data)

 

   December 31, 
   2021   2020 
Assets        
Current assets:        
Cash and cash equivalents  $173,507   $16,867 
Prepaid expenses and other current assets   4,867    258 
Total current assets   178,374    17,125 
Restricted cash   1,055    118 
Property and equipment, net   2,258    445 
Other long-term assets   —    100 
Total assets  $181,687   $17,788 
           
Liabilities, Convertible Preferred Stock and Stockholders’ Equity          
Current liabilities:          
Accounts payable  $1,500   $373 
Accrued expenses   4,407    394 
Current portion of equipment loans   47    47 
Current portion of term loan   600    — 
Total current liabilities   6,554    814 
Deferred rent   1,680    58 
Equipment loans, net of current portion   16    63 
Term loan, net of current portion and issuance costs   675    — 
Warrant liabilities   90,021    — 
Total liabilities   98,946    935 
           
Stockholders’ Equity:          
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; no shares issued or outstanding at December 31, 2021 and 2020   —    — 
Class A Common stock, $0.0001 par value; 300,000,000 and 200,000,000 shares authorized at December 31, 2021 and 2020, respectively; 99,979,207 and 67,640,740 issued and outstanding at December 31, 2021 and 2020, respectively   12    7 
Class B Common stock, $0.0001 par value; 22,000,000 and 20,000,000 shares authorized at December 31, 2021 and 2020, respectively; 19,789,860 and 19,572,257 shares issued and outstanding at December 31, 2021 and 2020   —    2 
Additional paid-in capital   121,587    48,435 
Accumulated deficit   (38,858)   (31,591)
Total stockholders’ equity   82,741    16,853 
           
Total liabilities and stockholders’ equity  $181,687   $17,788 

 

See accompanying notes to these financial statements.

 

5

 

 

VICARIOUS SURGICAL INC.

RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES

(in thousands except per share data)

 

Adjusted net loss and Adjusted EPS

 

   Three Months Ended
December 31,		   Year Ended
December 31,		 
   2021   2020   2021   2020 
Net Income (Loss)  $70,080   $(3,784)  $(7,268)  $(12,875)
Change in fair value of warrant liabilities   (88,262)   -    (31,375)   - 
Adjusted net loss  $(18,182)  $(3,784)  $(38,643)  $(12,875)
Adjusted EPS  $(0.15)  $(0.04)  $(0.33)  $(0.16)

 

 

6

 

 

 EX-101.SCH 3 rbot-20220303.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.DEF 4 rbot-20220303_def.xml XBRL DEFINITION FILE EX-101.LAB 5 rbot-20220303_lab.xml XBRL LABEL FILE Class of Stock [Axis] Class A common stock, par value $0.0001 per share Warrants to purchase one share of Class A common stock, each at an exercise price of $11.50 per share Statement [Table] Statement [Line Items] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] EX-101.PRE 6 rbot-20220303_pre.xml XBRL PRESENTATION FILE XML 7 R1.htm IDEA: XBRL DOCUMENT v3.22.0.1
Cover
Mar. 03, 2022
Document Type 8-K
Amendment Flag false
Document Period End Date Mar. 03, 2022
Entity File Number 001-39384
Entity Registrant Name VICARIOUS SURGICAL INC.
Entity Central Index Key 0001812173
Entity Tax Identification Number 87-2678169
Entity Incorporation, State or Country Code DE
Entity Address, Address Line One 78 Fourth Avenue
Entity Address, City or Town Waltham
Entity Address, State or Province MA
Entity Address, Postal Zip Code 02451
City Area Code (617)
Local Phone Number 868-1700
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Emerging Growth Company true
Elected Not To Use the Extended Transition Period false
Class A common stock, par value $0.0001 per share  
Title of 12(b) Security Class A common stock, par value $0.0001 per share
Trading Symbol RBOT
Security Exchange Name NYSE
Warrants to purchase one share of Class A common stock, each at an exercise price of $11.50 per share  
Title of 12(b) Security Warrants to purchase one share of Class A common stock, each at an exercise price of $11.50 per share
Trading Symbol RBOT WS
Security Exchange Name NYSE
XML 8 ea156428-8k_vicarious_htm.xml IDEA: XBRL DOCUMENT 0001812173 2022-03-03 2022-03-03 0001812173 RBOT:ClassCommonStockParValue0.0001PerShareMember 2022-03-03 2022-03-03 0001812173 RBOT:WarrantsToPurchaseOneShareOfClassCommonStockEachAtExercisePriceOf11.50PerShareMember 2022-03-03 2022-03-03 iso4217:USD shares iso4217:USD shares 0001812173 false 8-K 2022-03-03 VICARIOUS SURGICAL INC. DE 001-39384 87-2678169 78 Fourth Avenue Waltham MA 02451 (617) 868-1700 false false false false Class A common stock, par value $0.0001 per share RBOT NYSE Warrants to purchase one share of Class A common stock, each at an exercise price of $11.50 per share RBOT WS NYSE true false EXCEL 9 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 10 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 11 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 12 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.0.1 html 3 122 1 false 2 0 false 3 false false R1.htm 00000001 - Document - Cover Sheet http://vicarious.com/role/Cover Cover Cover 1 false false All Reports Book All Reports ea156428-8k_vicarious.htm ea156428ex99-1_vicarious.htm rbot-20220303.xsd rbot-20220303_def.xml rbot-20220303_lab.xml rbot-20220303_pre.xml http://xbrl.sec.gov/dei/2021q4 true false JSON 14 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "ea156428-8k_vicarious.htm": { "axisCustom": 0, "axisStandard": 1, "contextCount": 3, "dts": { "definitionLink": { "local": [ "rbot-20220303_def.xml" ] }, "inline": { "local": [ "ea156428-8k_vicarious.htm" ] }, "labelLink": { "local": [ "rbot-20220303_lab.xml" ] }, "presentationLink": { "local": [ "rbot-20220303_pre.xml" ] }, "schema": { "local": [ "rbot-20220303.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd", "https://xbrl.sec.gov/country/2021/country-2021.xsd", "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd" ] } }, "elementCount": 65, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2021q4": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 122, "memberCustom": 2, "memberStandard": 0, "nsprefix": "RBOT", "nsuri": "http://vicarious.com/20220303", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "b", "p", "body", "html" ], "baseRef": "ea156428-8k_vicarious.htm", "contextRef": "From2022-03-03to2022-03-03", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "00000001 - Document - Cover", "role": "http://vicarious.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "b", "p", "body", "html" ], "baseRef": "ea156428-8k_vicarious.htm", "contextRef": "From2022-03-03to2022-03-03", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 2, "tag": { "RBOT_ClassCommonStockParValue0.0001PerShareMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Class A common stock, par value $0.0001 per share" } } }, "localname": "ClassCommonStockParValue0.0001PerShareMember", "nsuri": "http://vicarious.com/20220303", "presentation": [ "http://vicarious.com/role/Cover" ], "xbrltype": "domainItemType" }, "RBOT_WarrantsToPurchaseOneShareOfClassCommonStockEachAtExercisePriceOf11.50PerShareMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Warrants to purchase one share of Class A common stock, each at an exercise price of $11.50 per share" } } }, "localname": "WarrantsToPurchaseOneShareOfClassCommonStockEachAtExercisePriceOf11.50PerShareMember", "nsuri": "http://vicarious.com/20220303", "presentation": [ "http://vicarious.com/role/Cover" ], "xbrltype": "domainItemType" }, "dei_AmendmentDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of changes contained within amended document.", "label": "Amendment Description" } } }, "localname": "AmendmentDescription", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vicarious.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vicarious.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AnnualInformationForm": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.", "label": "Annual Information Form" } } }, "localname": "AnnualInformationForm", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vicarious.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditedAnnualFinancialStatements": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.", "label": "Audited Annual Financial Statements" } } }, "localname": "AuditedAnnualFinancialStatements", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vicarious.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vicarious.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CountryRegion": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Region code of country", "label": "Country Region" } } }, "localname": "CountryRegion", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vicarious.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page." } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vicarious.com/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAccountingStandard": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.", "label": "Document Accounting Standard" } } }, "localname": "DocumentAccountingStandard", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vicarious.com/role/Cover" ], "xbrltype": "accountingStandardItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r11", "r13", "r14" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vicarious.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vicarious.com/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vicarious.com/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vicarious.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentPeriodStartDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.", "label": "Document Period Start Date" } } }, "localname": "DocumentPeriodStartDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vicarious.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r12" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vicarious.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentRegistrationStatement": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a registration statement.", "label": "Document Registration Statement" } } }, "localname": "DocumentRegistrationStatement", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vicarious.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentShellCompanyEventDate": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "Date of event requiring a shell company report.", "label": "Document Shell Company Event Date" } } }, "localname": "DocumentShellCompanyEventDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vicarious.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentShellCompanyReport": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.", "label": "Document Shell Company Report" } } }, "localname": "DocumentShellCompanyReport", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vicarious.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r15" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vicarious.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vicarious.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Documents incorporated by reference.", "label": "Documents Incorporated by Reference [Text Block]" } } }, "localname": "DocumentsIncorporatedByReferenceTextBlock", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vicarious.com/role/Cover" ], "xbrltype": "textBlockItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vicarious.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vicarious.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vicarious.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vicarious.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vicarious.com/role/Cover" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vicarious.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vicarious.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.", "label": "Entity Bankruptcy Proceedings, Reporting Current" } } }, "localname": "EntityBankruptcyProceedingsReportingCurrent", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vicarious.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vicarious.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vicarious.com/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vicarious.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vicarious.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r19" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Elected Not To Use the Extended Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vicarious.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vicarious.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vicarious.com/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vicarious.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r16" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vicarious.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityPrimarySicNumber": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.", "label": "Entity Primary SIC Number" } } }, "localname": "EntityPrimarySicNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vicarious.com/role/Cover" ], "xbrltype": "sicNumberItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vicarious.com/role/Cover" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vicarious.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vicarious.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vicarious.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vicarious.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vicarious.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [ "r17" ], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vicarious.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_Extension": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Extension number for local phone number.", "label": "Extension" } } }, "localname": "Extension", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vicarious.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vicarious.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vicarious.com/role/Cover" ], "xbrltype": "trueItemType" }, "dei_OtherReportingStandardItemNumber": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.", "label": "Other Reporting Standard Item Number" } } }, "localname": "OtherReportingStandardItemNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vicarious.com/role/Cover" ], "xbrltype": "otherReportingStandardItemNumberItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r7" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vicarious.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r8" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vicarious.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vicarious.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_Security12gTitle": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(g) registered security.", "label": "Title of 12(g) Security" } } }, "localname": "Security12gTitle", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vicarious.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vicarious.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SecurityReportingObligation": { "auth_ref": [ "r9" ], "lang": { "en-us": { "role": { "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.", "label": "Security Reporting Obligation" } } }, "localname": "SecurityReportingObligation", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vicarious.com/role/Cover" ], "xbrltype": "securityReportingObligationItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r10" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vicarious.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vicarious.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r18" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vicarious.com/role/Cover" ], "xbrltype": "booleanItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [], "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://vicarious.com/role/Cover" ], "xbrltype": "domainItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://vicarious.com/role/Cover" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://vicarious.com/role/Cover" ], "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://vicarious.com/role/Cover" ], "xbrltype": "stringItemType" } }, "unitCount": 3 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r10": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r11": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310" }, "r12": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a" }, "r13": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f" }, "r14": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f" }, "r15": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1" }, "r16": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r17": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "405" }, "r18": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" }, "r19": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-23" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r5": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "g" }, "r6": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12, 13, 15d" }, "r7": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r8": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r9": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "15", "Subsection": "d" } }, "version": "2.1" } ZIP 15 0001213900-22-010596-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001213900-22-010596-xbrl.zip M4$L#!!0 ( ">%8U2=#6U!K!0 )EP 9 96$Q-38T,C@M.&M?=FEC M87)I;W5S+FAT;>T]^W/:NM*_9R;_@S[N/7>2:0#;/!)(FCL\4]H$")#'Z2\9 MV1;@8FS'D@/DK_]6LLW3)"&%M)U[3GM*L*3=U6JUVI>*X85&&+8U,!YF&-5@/G[=.NZJN M:2QTY4]")*GD"FAHU6<#YCMGDW[C0E<6V37C=V5A5X/::44^?HD.O\=TP'A= M7YG3##,D]\76Y:P[B^X_ZYID+K9HUW:'F,$:P@0<"-2_(3CD@'8L_^+QU'5(*:>1VW"3E$=#TD>C?7Q*:J5Q0\/DE)X MN&G_I90O"H4F?/"YH'C\K:-3V0<^UX>%.3Z$<]P 4+HX'?6>X9GL P%IA0G MWXH%+)R4@#1!ZU0="Q;--X)0Y+O>$&!IOM"/68OKH:IK#[FL MQ*44_&7V[.<8LF#6@(H8^4AIB)W/Q.$LN8#B9[#Z2OES#!1Y7K5!96%+B,D\ M/0M2%#L7[9$D)!<8P2D"_4I<./0)]7MP19ZGXH0&TI X=O-]H:-=U6;Q<",E MQE2/! ^.FI[;H@-N@FIR ?,0(;^(C-"O18.(V(= MID^GSPV=MW0-XB(Q%1)Y_)5JWQ;7;'GP#%TR$E^ S0'^VOHJ%6"#N*R,&3F? M32&$-&M;&09+N690V+),U@(!X<. I6_E\^RG!\VC##1NR<24ENSAT+;:S-8& M3>S>8M,C4H+SK$E3+K1%1,NC T:.^=G47X37IPE(]'.DYR,IOE_4LSNL NV M)Z,=NPF*H0\V9,,B@IV-[C+;*UCK%UAE3%S-H*0):@TZR7(B(_UOB>,N>/:/ MV.8]R_!E%LR5%1$:$DP]EYP'=DT>^H3 PJ9%%!S:&OB^D;061< $T>G=.&;& MV H>,)Q =E=YR\<*@WMZWQ9QAL%.&Q? MX,(*0P/[9Q#WA$\S;N_[H.+,=P*8X+(07!Q,-E&H>I?BSD:&S/B='^BNV,%RU M79B%/[QH8FV :BMFGHIRAH#"'Y[?*LG<\Q3HUG\ !D3OA__B5GI5.?'\&_ M]RB#K9".'PGQSTPPUT>SXB+IWFDVYX*]FA$5YUHMBL"'7DT'<8G MDH-I\-[GTP_GYTD^10(I-HT>?-5 2_(#ZDP]OZG7.I4R:G<*G4K[+*GN&%V[ M4KIIU3JU2AL5ZF54N2]]*=0O*JC4N+JJM=NU1GUK-/BKM):2.TS[AM5C-D H M)TH)I$B9=.ZCL%<;K2OD"P77D]QYS4DGPB>/Q\NVYO'#C8=#'K1I^& 62'@F MKMZOM0VE^>48P/VL)SF/+W9^$O^V[+9-)7'7X@'"T:K4.ZA5:39:G=WC \N% M>F#$(&;#((WO1B2G4*.%Y,R!?HCL+F)]\E%" 11XKL$,@%49@T5E@;XJ:(Q3 M(>=2Z1VS@]LM'%6+.+;+T$'XG6!0380R1)Z@)W)%,]$/\PA(7A9A>4F$F\+N MJ?A64;0LM]+/#%\5K[I>YMVR/!^?T+G9"N/Z.IY,@'AB1$YMX73^_4_?-S)O)YIDG2[WHW0MTC,H3V\P M'K6,W@=M9_+WG58;CH?F%G1Z%-[8^6VM5&C5&C=MU+YI7<"72U2KEQ*_1M\? M5,88M!NGF>L9=THKPA11AVC]@J I])_+7)?6GN>SW-G:42DQB@M:(R:!:QT FZ*4$S)3]V5;'V- M ND?]RK?<\^&D\';.$AYQI8'01AQ7/N)[]+%D_0-=()104P\@C/X10T3_,CT M]6Q/[8SMZ06V5PV3 (TJ<:-YW+3*+;/:HY.+[2GI&4X>X)/CJ5SJ)/W[,JRR MP+ .'M>"$*0F9. E[G6T+[GOJ6/R?*QOC7MK" _YCBN9(]/Y&SNC;R$?]SW M*8ZEW": S>>Z MNS6)T#VY!=U3T'674!I\7(*M(4?KG1-2,7&Z9%53V]/:$#'AMNQ1U8TX[)]9?3=&E3;A=2V&3=#'3N_PR;K MX^$:;AVM!,HJ47,1"K3A-L%8 66YQD8RM0;+X?9%L69\G(T432 /.E"*M;Y' M"6-T>?+HHV3E(""/GS*."Y09#C81&1/-8\83=\U +1(ZTX?;TU+;F-0,\L?N MI^,H&6S:( SF=\-9;Z77FH^5NG'[I-M;WU(+V,&65-(9^5=IH ,@ W$Z#G>* M9K;V2\=74CB9YSL,V,YB*__YUXDB'Y]2Z&82IV];!%G"7CKB9IOI<9=V?P^\ M( PKK)/(P&FHTKA:+$#/]0)DI\UO#5NW>XWWJ["9 ,WC@U7+RL>':T1F10L7 M Y(O;3 .FGS:+]G^7Z2^H6=:M/NT!:J748*UGSV)R\>2],M2%_5D8=?QLBH< M/. :^ $S5YQ#\!7[FQ]DK8O\I $H9G[ (!-3MK_G!^S_B9O]^7&S;6NR'QX% MGV<2.R_U"? )_$Z$'3!DP K@OJAJCY%*3'O$)8LW<-;G,3['+9P\QGVQ:%:R"U M5[")8">9T6M>O7%NOTKUQUR3['3-5^G9VH+/0._O#0/@JZLMIW%<5N86?"&W M/5WNM)3P>_XQ*QYZ $V7\!W%2\Q%%077AVZCVUUG"74[S=%Q)7ML5-,[7?GU M=&U- @!%7)O#\?K>E]-Z7#E0#]\F#W[?K4I$Y"F\5;G(1,M%C5*/N*]*Q^"Z ME)G[;W=V>!:]1]RME)$7BZ0/M;3(2]-V)C,P=3;Z=0ERP=)RHHB$ATX'= M C3F_Y!DIV]31X2NEPHPU65+.L"?EK>69^KPZX%^P9'61QJO(']KMDOYZ^4H M^!LGHV2V-QD7\[5%[$^!)D_4UUQSVK4 M-Z!EMD'>F5<#,8:Y]%P;=CT79=O-([>G'BA2^DA)G1PIF[P M/#P[ZK,Z<)Z;E][)!F?!3]ZBFK<=E^8/GB*'A I($\" H0#M"#G814\<(/JW M#Q(Y_#)+_Z7$?U0B\:0^D MBD>]G]O8.[F;^**2#S%R ]<)<"*>U1 :G=L"T<> L! P0[!L)""!9Q0U,>3? M@HP_XV"H[N9@V(V<]66%R1>W5J:8_:WE+.*@07?MW^6LR>WTK-G-RE]62S>= MCGU_96X2*OBHE?\=SJ[M9('79$WFZPYVF9VI63J/E1"D3I F,C4P;H!&?2(J M!1>S*/M[!A4*&+C3XQXHG,TCUN>:VN&I%4R13KJ&Y1?6^^%X*1-&+I9B\?[% MHQ0ZX%,]/A4A^;"S(4KR'5Z2SY.1?N!&4>-* &M_[Y7K3%.H/(HS&S@'-[$M MWOJW4^>9ZQJ]/FB!2C27HH-:;XH/K@\3^Z4:(<8+@;#DXXN.!%YW_F:7Q70J MI_:W&0EDKD=62T@BZ0IB@-E78H"[6Z;9'NB^(-2\S&*Z1?;WYO:(L9)D!.V& MB$DT!AO LD4,SP,SA?<"O$$JD[^'S!!Q/?_>/F>C0&9../:1 ;CY9K)@5M#B MDB?0A=#+L+"E\20(UL2+MD1FA+\%3L>N3OTLIKXN@I@ZP-,(XOQ^2:"MB>+B MI:3*N#.=J'\=+EH.O;L?3YG*]:W^7=EI1'H=56^,1&^UQL 7Q?<5&43>75=^ MGR*$%[;9^R5MUQF:+5VO?UUD.*=/@:9'CRKYS5P>9"2D)3$JYF-S8&W"/5,)BJ2&PYQ M@SPA'*,@D>$16[+AS.<-*P1\1!'H3&/NW/QO6$C<3D?!Y?0C=!N^E!*U/8 M2XUJEI9 !\+LYM6HBG1:"DU9^":?'B*#)WAUA,$*X<7>+AA!/*R#+0LL%4U4 MA3V!J7[ M>Y[#[^,G1*S(F59V+=( )G_7/A#=2\ER7O_@@>"\"OQ$UK8,[F-;W+A!]R$-^=R@+1]-K9B,>HJ.>^@,0:3] 1S,@-YF;,3VUV M.XWH^WO@ITY?NLC9R$WEH !P;=E7X&K.ST.0N6P-'_$4)''$'7$R%G+$2PT) MXTP$207^SE%!/1Z=# C9CCQ%2E+P$%P2P@$J:6X4Q/Z<$T%RQB^G MH+=QS,F$;J_,,DV+)TYR?(2JSH]RX*>5$\TIGW+?N! M_GH-Q.90_]>7\!T%(E'U$I&9O9 46:SXNVI'@N4)*T7J]NO68G2%TJRP)?V: M>GJ- >M*H%Z=3)E0S34&KG.WA5LM M;Z'S#"/_/\:W&V>@R_&YC/ M7"F*M2]>-57/V[6+>J%ST]KB^S)?<$R7N"DE,H856WAQH9_A>/0,U[=M]_=> M=1J1[S-&Y$9T#]PI#7L\GR'<7__Z8."\4J ,&FS_E5PJ 4^PRUTN#DBX=D$' M[K1[%K/W]P0\[+&^[<)IJJ_UNU3;U-_$LRC5N["B:[?+HN7F;_BIT;9+7RS2 M3HLTND&Z0OE6E^TC.)VXP?$YIHA^:U_EIBZMC6WF O8>M7'3D"^Q1)*G:*&\&9H'EUBRGX+PVBW M::>0*TG^^WZ$_/)?+W7^QM\N=%)\$#4"XB+RW&\E(E\GU8%>]7J#PG5+31:Z MF=[UE[3DLCI\?6ZS7I^FGV\XGIZM;W5;]PJRW!_V_ MKZSFD]Z$EIY4)3ZU+/+69O1[?2M_0P/1B8%VVOTL"I2N.3\<7Y M9#D53[[.RK=JK?1X3ZZOGN^H5+$_Z:.T2MI?Z[G.L'?O7-1KCEQJ%COZIP)M M5]K=T?6@FVG?CT977W/6S=W)M6NFI;\56_VA#.M.ZW%8U7'C>\=UGL>*4;VH M6-WO33K,#.J9MG1/%'/T>'^1,]//EU>/WN *9X:=>X<]=OI7W]6+KM(8?/7N M"TR3=?N&L5R.I6ITDNS=6R1XGWS MF^M6[9OK2;62K"1M)5/!D_NR](65G^Z;Z8M/!=4IJ6[&7]K_!U!+ P04 M" GA6-47N=30;X= #'_P ' &5A,34V-#(X97@Y.2TQ7W9I8V%R:6]U M/4Z?,\7O_Q=;LF>_9&YLM?W#]F NST)?Q9WCCX= M'S5_]65;^JQ>+Y0^?3@&0*XGAD@\_X?=]H:'Z4<6A2Z*P5P$LFM]B-&#JN[['/3N#Z??9_ 7?A:<;M M3C[W.; L]D-PEY6+Y1+[+&UNFY)>\@++][)7^]"E$,BL.!7H$&59$#^EW6.^P^1@Z#IW@@WA-< V+ &%S9RB'( 20-? IKHW\,F M IFT!5 %7N=L&+0M:4:T=-^7 &H7=Q"6:/?R.7QU(#T/R1"G@"<'TA\( I=9 MSCWL<9N[KL1IX4I$/B'-TEO3"-,(&<7CLL,:'5AJBYM]6,Y)7XHN:_X29N#+ M.Y'/72&5PF1 HEDHU,B_PI6Z3@\HRP/RZEK"!$I%\4]"0OP[2/;-A8^V_@+E1WA@9 M&&82&=ZYDQU%.*[H(8TZR/O##A!K(9\[YAX(@& (I(+(B\2=AXC"[4 5@&)C MUPO:(5$A00%B39)T(*:D%D]_%EH%4&%.AS;CU UZ0!] M=+SM50,Q>_GTT8D M4I&%>EP"K2)JB$PU-*8E;5H(#I> /N2+KI;5D[1@)-<"K >DTR%*'P:N%PCD M(5@0X/.G )9PD:K@INE82'KY7#\ [,>3 Z8X3062P0H( 0@L.Q7LTKF#]RS0 M4[*KT0%P_AT JT^E4Y@)KP,&U*! ZS 1D;:T.^$H3C>?NP-4N' 9^-J6N'U# M+MT"J$6;]P3AZ5Y:EMYBP8"!.(KOCO"YM'#O>MREK5=S(!9@K^&"LH$=X3#A.U!?T2QM 0+E?88Z6#K[+,6BT7P')LWGJ\O;<.@V-W_V M7%"4G5V@ L?]B%+5%V3X*),LGPMMLEE&&(ZY*ELLACS3&+MM')\WV4GS_+QU MW3@YN_SRKYWB#OU]W3@]#?]^,$#WLN/W\='B[SMDZG^ZO0E'N1.@JH B0@C! M&-[1QX%/MZMKP__!5O^.UI^NW$@YGH4 )TUY/_"+6@B9VENUT^D-;H MX[RUID;ZX[_KE6K],-K7+ "?%Z9#-I54KX9D>@*[BU]#U(!H/[J"_5:J%]0BUZ46J1[+B@IT%=D& 9@F1SE9D$ MLTNG8R T8(^#K(+'0$3%)A5'G=QE>[7B[X4D1N&?&T59'XB&CU;'.1.29%IS!>SF4"S3;VP%Q)_BBV*DVR1.5)Q2^=;.E\'U?"%W!+* MXN,)@QQ.=P_CB>I4GB@6J@OR!-LRQ98IUH I6MP2RM.A#H)CEM-"W% J5*9R M0VG+#5MNV"!N:'1P>B!?6_C,TK$CA<$$W/.U.YNKEX&\D0D.\%C MO#XPAH&.["23\'@J?#IQUC#0!S\V4'$_.5 (F<<'0I\[0F]+?" I,$487QJ- MZXC)EK:WEP ZG&J<@9B)IVI2$'04X0>WU M<:_\UM&X)=YUD>*+.AJ33I2]V%R;(/1R[&V,"'WK+]E2^CI0^ESO88+$$]9) MRD]8WU+XEL+7DL*S/8+Q.3MIF,_P >[MS?)AV: F)J?!]TKEF#/2[L!2)3EF MRN OL-4Y_3(0D0B*S?+QT9N3'KYB97$/7Q(G,U&2@9&M3-G*E#60*>3.HY1D M_ 5X1-Z!'L43N38&JPEK$-D!B/M4F&+0!MK>*U&2?VGU&G)NP<-3QAT;\;]V M=]EG*:S.1W;->^(07OL[P$Q+&)WM[H9;>7KV;;R*116>E,H9E2<5V@''[0@W MNG9LP8ZP4N$ H/ <2W8 DG1=#)%3Q+&?/L"L&0"T7<%_[K8%"$& 8W>7FZ>]L)?V)$ZS/>&6-=,G^SP)ZR_AKH[RI?.Y M*(^=TIS[5/O")I.1N<_V/^X5V; P*+#F+:8OW_8#U^OP$580Q<5!)2R)81WI MF0%HS86+8?#-?"Y=_P*S: @&?,3:@G'3%!XFT_M]6%P"[X'V#P=Y7]RGM6+^ZS@X/]?3(K.EABX6-Y!PR-]1EPC1ZME^OO\[F# MKB+DHLQT7=<6EQK(4!//=]?^A]_/ AK&4IW(5[%5:0%,!\ M>2650<"0C;839!7_/(?4>)Y%?D8&!!J@LV=I?UH1B:IN8QG5;6$54C[7 <*Q MG*&J- $NUAO1'=%(X-XDO:'I9ED"6N8<42%.$"[PX8.L<&P+)8GW(' M*+A3XPIW- 8HHM^"'6IC*1]Y&%Q$$(H9+#)#I@T1+&&1!AN(CJI:$<"=> 9P MNH*J=@#E^1Q5G/5''J 9 %85:# #2F,U26*[K(!DHQ2>JGRAC.]C% Q?N(_X M_B9MI\/^ X+9XA%"U9_L&RQ7[=B9#3A65-,$8N-W6/J6S_U;N(#5']SN1:\V M+N!P8#E!)_%V*[#9UP F_@^7C'SF@)D"._=5C=%U7UIRR,YE* M@UTZ]BX=G>, \06P)^[$"HN,GSEJ?H8^!U#UD@J=$@5RL8X?J$5CB176[_91 M]W%@T+80-EH-ZH2.16"F"88V1V.$A!O^'=B^+HV P8;H)51R$UD=E?+05^]2 MP9Q-)D?+1X;"'6@,8"$FC^KDJ*(.MR2LEC,R2YMU"9@7K0RN)9?CNRBK:2$H M#VW'G[F,:-8(#EM31@A&(9]#[@HOIW$7RHQPK52*J H\+0J[(AR1BPD]*^?H MS$">3E^]!CNL19Z-$)[PF7RN>=W20*%]UQ-8!1M6ELZ@YV@A8U(B"A#/>!/7 M0Z@V6;7=W;5;_D< M&'7B5VB^F<+UL=0:U,Y@*E'%V B5190ZHV*YD91S8YGS2HRAV\RM]^*]Q],^ MHJ0M-!_@Z1B,!(=Y<@!G91?4O"]]M-DC @5\.:27U&D)+>HVD"/*1K@\BL8$ MW)NJBP0I3/U^:"Q0PBXL"XR)0K;JS.=2$F5Q58]LXO6=P.K$ZZ,3C'X3^-WB MNC9=A60HCPIL:.6$P+.>8T2+SN<6FK; OO?!J-)J#$ET!KLDJ-U@(R<(X0T! MG<*X8-^'.\$MQ^[1L4QM2#8#)E3= DLP$L>C,&#S2M16-C?$S-!Q0O%@<13) M*NH42@HBE5G[&1-?RK^6)$?'MLC#%J!W#:F.^J180G0*FK4"#MI/@9)$E*1ZF,Q M0,=G1\*[OC5*")U,](4R(^R&$HH4F(Y0,F9SO!(J722:4CYD5T-J5_(1)VL) MZIIRR+Z!W,';SQ5L27?76JB7& R16%RXK$-V.QH"] V@!VD>LDO0$&KIEPXN MJ#P61 G?PCNO.L#SLL1X?'2=B"O\&<455M^M[>4<*0:UJT+OI*D$?[+[3%-3J' '^E?;?U&#'Q"QKKB3 MZ!4%2\KR^Q2OR1A'HH/XGF2N)6!V@]TKSP6@P++B/ N'8BUHY@$:R/:'M8]I MF+"MEPER7;F'0I]V :PVTC5PV1H9JN];-"6-:..*K;'5X<)V!4;2]8"JF\^= MA!W5\)!+W/2#A(8S29]V9+>+1VWL%B3)+X5'!]+>GAA#>Q3L^@P#T9$>3PQJ M%&6_(G@3DTPITLG8=HK'3< "6@K/,=3^+ U)Z%4RX-P1^[+P*9]R9M 6 \T= M4+40')J"@1+Z!E 0*E\7]7"8IV72P:C;0+GA7*#Q3H_\-(9VI7!L M208W3.F:P0!WV$1K$F W_=![P\$FB=LW9;;3,EWIJSA#PE$(*L*$(P$(CL)S M"(?5I#9,G^RSX]X#-^R>.P[U/&Q%3K#7(PIOT_Y-3:A>Z(OL:C18"@WY7.P, M#!OJH9VI10J8<;9V'R2:47J\*\"F=-OH;U#OD''I2>V*2?N4KUUYA[P !D^ MQ >7SN%'3Y'I#2KY 0H@7]7!U ]T8'N"<"=8' ^LFG.)6]$;D)3^1LQ.NLNA MZ_RE3"ZR[ TZLI$]XJ/,B\]R^9PZ4%@CW03.HZJ_).J2;E1.:.](/32LH1M@ MY$B%L3V4[F-N5W7JP[:,8U>[##80!!SQ)C$[=3U#5PF@$EX1TDX>\W"G4/60 MX%&H1-0#KD+UIW7!1$M$%G9$C+7C3.]9U,$0Y=# 08+0"X!7$;7N3.R0M-8= M%=5I('!=K#EEC6AO CCV)H8-P!NFB_\NQ,'8)#$$]\&!T5WH_U=C8 M>90<3D1X*>5!4G.! M3VZ &>A' G =*S(?$"X)ARD5QE54%VE&'29"QE!K\P*SKY\>'+U[>QTMU1'-I@!9.A^.PQU&?II0U6$AT2+WY/FTIW^<)+;Z-D= M91_1<8DNEX@T9<2@YU$WLB &4V/ (M'2,.+&M+X<*+F5%:>*'3FNTPE,]88G M7(I4ZP0".M0##N0=22LU3]S]D_N^*P&#VJ_;%K;H2G^.'YK.X#BAEYP1QIX! M8H@>0(33)I^I2O:7)!62C1,I9^".6S/:41()898$"#:*"0&Y8TPN$H@)24)K MP6"4&E=T0FQIE,M_U.F^$[B1K3'1L9):6GI9\.A59C9(SEHZL(B-*@Z%WRZ0 ME.JLBB;?WX%$-T,B !1E#BR*UQ"9JC6Q^"7)/\_T- 9*H@!Y-L#<:'+YC-3* ML:H(B8#. #U7*'9?=%K4;6A9DUMGPB\+8E^)2&N4*.R !0N[!U(Q"MPFB17P MGTE>4]WK8"M,F25.HCE4PBW:[9[KW .XJ3:XZG6UU_,9;AQ G?[ACV$';PHM M;/7@H'R$)#RA^Y3V'] 0-B[NRV$"E2'# G'/#W]DHTV=9.2@';B>\O'AXG1> M"[&R/CFAA,;WL8%M%!N9PNE^AE$3F_RQ.H[/!BZ:$ %0GLF'P)H6-7:5458 M#F\+T5&H3\?=80L?'/DY)* 524Y3HKI'+,:5U:$-C%7*0,*?NTK= RAAOA4[J*(S3L5?MM$D5A'V6M8$-#G I;1N1NG6J9 M.9%=1E@BW4U1E@E+FB <>T)9MF1!*YK+.)C" A2:" XR1:+)5;X76%#/Y/U= M\@F,SI1G.NK*SFSD2>"+CTM.U+_ +?'V?'(["]QV"_2@BL@[MD7UPF&[/S\ M9)F8F9UA_=^?F_C_G2/I_F]F0MNR6X L_?@=NE=U_L0%Z 2^.AI8%)W_IIQ( MU_&\3\=8BW(!1BI(\).Q+NGJ%FHQOKG(7R#0LO?*8RI[;S.F\N+?S#D[:=R< M7?W98JT_;[[ '^?L[/*DH+BJ==NX;5XT+V];[.HSN[INWC1NSZXN6^KNYZL; M=ONUR7XT&S1,5E;'&Y2G57ZMWWI&=#QS*\/F3V4DM64D]66(4$J_L)O'O"A!S09_C963KEXNL[< MPDNUJ(S:RR':SG9OUQ)=F*E8*)4/I*W7#<:NP/EW]>6Q.LS$&%2!>"_PNU X MD]4Y9.&P$3>A[)A2QWERA2BZ_-=.91(_4^6/KGHN:F%C6%Q'GC MK0J86B6E#%:XB$8E3\K?*?1OJ,OM70-[OGDC?[U\!"IY(V^_75ES#$8YBE?KS!>^T M5'X_YQCW='-N_H//:5P^!IJUMB]WCDZB<&.72Y=A=1:5_=USU\44+TNJE $9 MJ^!587>O9.Q54]SS8GL]H ^,/^-FK^A$>(9^(_Q.K6+>E9\&4ZZ E]K!4FGO M%;'J5',BVE\ME%^!'JW5W[09D2+;5V%!D-FK J.A'>'S7ZM7*^^J1KF2.DC/ MH)R5 0+F86T1!;>,77RYX\UU6*@0?DH]M=.;RYI3C((W=XA?)A[64%BE:7L_ MV19ZWK+W'[5[\!;K.$';$@L%-AXTQDQ1F '^HS3K^BX[6_ ^;-V;)HW'*':\ M'?F)Q>%2@X('ZO=C3.,=.%@KY9@_#>K18^H4?"OP16=S]QY;K[\]BL<^\4NB M]ZC;]M+SA\.4AA=,.&L)ZN>KT MX7G"G^,L7+.TT2>O^41W<>"T]FW.[,-R9J=^@VB2]%\@\;14W3,.BM6ID*QU MUFRI8M0JCX=]_8*D,WS98LAEW$@J4;9MCO'FYKMT][/V],TYMLL':Y!RN7)O M89AFF4W#*XO'5VO&7CI#[,72 ZH&H&<-\CN>NIKA7:$5,B3DJTV(QDE[; %JI5C(JM;GV\)00VF)T MO+Z+KQK5VF/3!-9*)J]S8OAZ0;/>HF;GZ#S.0S?8B6,3<-CV$H[H7>&ZU C7 M =I&NXE^ZSL6]B'33=%8$VPI?[2.J%\O:%Z<9S-=>?J@FJA&V):>O#A//\GG MMG/44*W1/7AAA!UL'XG"E,K+/+,>I$VR)6_E(G#L59^S)&%%!26P;VZ0Z*Z_ M\J.@L9_VE+\4'^[5'^C 6G,F#"4K?;9"]1B.O YP0N7VZK=W;?;VH9"L'W-. M]3AD;#-Y'G"'-_^\75G2>7N3<; V*?G/'KUXQA+5BG%PL#8!C%KI.571JDS[ MT_#XYB;:6:TN=E&IK4U]ZD.=[>O.E5)5U,/:? M+&M#,V':?JIO"WA>0)W=\?L@JQ?#;[E-P,M5=GZ?WA-B<^VF>M%8//ES:SZ^ MFHK.L7YCKXNB:T9]?V[UUZNGZ/K>Z^LRML[>YO6"9@UET,[1]+C4-IKQXD;3 M$QVI<1Q2UU#_5BP4B\626L*0Z]Y:^BLY)0/NX7_J3ZH-\Q@/_+[CRG]$1S]F M.V/WT.J"Y? =F@#\S$ MQ?F:L%A,4VQ/$1/^IW<^_CM%6[,)!K^'YN%GJ>2=L$:'K%XWZM6Z42Y6Z9%* MU:CL%XWJ?C&D1DJ)7X %^)\SO#",T2.8@H]GD^AY?($@4[0 MIQKHL41:JAO56MVH5=3H\.=!%=-9JVQ<4([V*3HC 4/7'.^?6MQWB''^4EW%0%&,)C)N[J;4R6(];ARL6 MT1X\OM/GUD/UIOT9S]KW,.4C5Y_V9YG\IGER=7ER=GY&GP'&WFQ?&HUK=GO%+J\N M=^GWSV>7#7BD<9[/730; &-S21WDYL&6]67AU7Q8^*6VOM'Y*_#PS&V';6;1 M+HBN-J^?"=,9:][0GG:SA/JX7E[CSG6W?1=TXP4\W/?T!Y%57\3EM[3;"'PD M/@R]*CP\I279\]-# M\N]SI:$Z)V)#^C/]$3G\($S*29WH(K?HU]87>/.A3>_F#!#&R45^7]\H/&)JG59]O?3$+48T>\^5D^_YM#6N^PO>;ZER/6B=/&R@;T% MJ')*2"CE^GF$#'AZ).1QFNVIPT;ZKF:4:G/%YO["[/\8.;KI.,RT'+_(*0U@>0D_BHG=B"& MQ$Y?Z]FI-%H:+V;)PQ-B514\+83 M>H&#"(]$3/FX[7SIN^_[IYV.@]Z]_>U7!+_6[ZZ++BAA<1.=B%$8BWD&_05L\S,B O*B$2G(DD9T00,^4I-U/#"VA"Y[AZZ7PF/A?QR MTUGH3K1.5=/W9[.9Q\44SX2\5UXDDOT$^QKK3"W4@GE0_/:C7U,5+_C<]:3Q\8Q^R2_9J]"W!=X_G_WP M./VG=AK>CC]_OLZ7;*EH0A*,X#"X:CLFOB*\6=T3[*38/:-V3 #PZPMF#,LSHB)+801K+,=$F9U6*(_*< M7)GYF',!%P1N:3%CYM*4P@V B5]:)E6:4C R ->1&<#5W")NK/ZI@/KB(!JW MG7QH9$#4"L5D1#FUJQ67,$2NN7*9"0V&EM+RU\$K$IDB<9>_M>-4$@4\Z_X5 M3!3$ K*%%&$69>PPSM*52DHQ46[3T*;)@+:CJ"F13C$WD634 M=N10:+<\G^\0F@?)44*,](X+:G=^?3>*A4L)+*,-E8T" B(B)5)3R/"5*I&[ M3K6A]U:6068=Y2#_9X3,\/#0D(%"V O&>F7T?VJ0D$F'!ODT^5XHTK/%(JOA M%@7!7U:$XGN]:K0@<"$UXAOU9]=KDK^#5R*R4CLHYLLM>:Z948H9L/]UUZY_NX<_E*ID^85N6,N]0ZQIW- MU_0'_+%B1SCT_$.]S:GGF/9;'94BD>28VBN[)]BVG'OI\RK!3\E4D$[VL1W?>PM'\" L]T M+3TB^Q,LR35)AJ;=,6% PW,8AS)XOTSQU3(S]=ATX4VHTU3$ _N)J,) M5+8N)];-[F@]G',<3=[K\SF1$56D)VD$H##T&D'U=KR0]O^[;2T_SS@8_@=0 M2P,$% @ )X5C5!9B@D@A"0 &6H !4 !R8F]T+3(P,C(P,S S7V1E M9BYX;6S575USV[@5?>],_P-7^RSKPW';>./N*(J]H]DDTEK>I.V+!R(A"6,( M\ *@+?W[ OR021&7I!P;)O/@R-0!<.XY((A+ O2'7[<;ZCU@(0EG%YW!2;_C M8>;S@+#51>?/>7VA7.%5"CW MM?6W_>1?7/P#)>SNW/Q8((D]K1>3YUM)+CJFW:39Q],3+E:]8;\_Z/WGR^>Y MO\8;U"7,Z.;C3EK*U&(K-WC__GTO^C:%%I#;A:!I&Z>]E,Z^9OUMH/8%LN"S M7OQE%DI*JLZ0EN1<1I%\YCY240^I9.2!"/-;-X5US:'N8-@]'9QL9=!)?8K$ M%ISB:[STS/_:Z'VK#\1'@O P,K=GONV-N>Z\FFI4;BWP\J(C%ESIZH?#_FG_ MU%3^Z$TMB^F#'Z^4:1L)/V[:!LZT 8:9JF_C.HL;7N@KAAPO<#<@& M,]/?.U[24#:X?2V$J9Z&]A),SUK!Z_/>-]8-^ :1(TD72SM@'+74W>#-PMA] M%-U\T=?GBB@]CF%4X/5Y,:Y&QU)+RSCMDWB)0JJ>W2G3XGG.^C!AQ(QTG_6O M.=YXJ_2%!PRN$+K7"@X'/4R53(^807'0[0^2,??GY/"MN0!B0T8'C2?Z MHTR;H6B!:=3X;0*V87M-X'Z#%D_=JH1W@COD_.3\2*3LDVY3\]R,^^JYSYG2 M?>621JWI_HY7YD/*;"GXIE+01#Q>&D%684VDXW$18*'GU#SKY;7*K+P'@%%0K!;/WM:=+-%/R>4: MLL6&?5$_BC.'*C- G7DE<\B08;_-CMP.+/1?RI3TROFCX]VS78NB@XP[?:YQ MQ:SA^N/T)C9")ZP;SB(*,R2B/+%_8B[D,RSF:R3PEV3>6+#(U'%,%:_@7'YF M"[A2.^ !+GU'0B"FY V?A<)?Z_QRRG!$9KH\)'V)_/5(76[U MH$\DG@GB:]!@<'+6K^7F:S1U:QMN&N/ZJT4,#KXO@$DT[O[U MSGSLQA_C; *3VW0>?J-KM3BN(5G$[;NW,:IZDF@C"NG[(M>V>O*.-*' D+JB M:&77-P=IM,!%IJ\ZGSM2X4]8^H+$P8'#_;AQC5=$*A'= M'=T'53Z06(LTVHAJYN!TS+TC(\9"1*_Q/1<51F21K="_0!B2_9U[V?\(D5!8 MT%T=Y0_ K1#?QAG2_^P-)C!ZCB8CN>H8<(ANA0-6TI %_W!OP7R-*34/-Q&K M=184\:VP : -&?'/MS7B\L%,('1X];W8%VF='7GFD"/_S;B6OHK(GU$8XY7^ICMD4N P M-[YDBJB=67WW-03N;6O8(:K1FEO)@EH[3(AC8NFM$J;,(L,RO?/(%FAN(0SJ M[C 1CLF-=0@"T0D+\/9WO"L3_@#: N5MC$'I'2; ,;N9(!LD=G/B5P\RA]@6 MB&^E#*KO,.N-Z=V@[230@9 EB=?J5IL %&F!%V7,04L8/FN0P-XZYCH) 8"F3_TQL@S)K+/ 6& *Q!A^D M.#(FW0"8?9==(SS&T7:&E7#M)H MO8M,08D=IM#F.C02&,'=.XMHML"'1$%]'>;#G[EY.K3FK/3^\R&JT3I;R8): MNTQKS49%"0X5^Z\;K6Z>)23KLS=[/$/6[X(HS(IHA39:;I@Q M*+W#U'3.*?&U2FSU1<&=V/HOI M<@F-W#"^T0Y4T :=<)B.'E"<2!EB<:P?A5)M99XZ9 M7>XJ5A2H!4.0+PA,VPQO989\1XR\_X[L8F8 M7>D/=ANLT$8; #,&I7>Y53<,B,)!3/**,,1\G?3M P/N)E25:K8A=]F@OL8FP=,335D(]OV[@9Q]\/V/_ ^>[%!L1Q[.P&)-?<(4V30W!IG,5NNZT8 M"EJF;2$RZ5%RXOSW(ZD?EB@^DI)K2/9%ZTK?A_Q2_(BD?I!Z]^MN':%'PN.0 MT;/>\/"HAP@-V#RDR[/>ITG_?')Q?=U#<8+I'$>,DK,>9;U??_GSGY#X\^XO M_3ZZ"DDT/T4?6-"_I@OV,[K%:W**?B.4<)PP_C/ZC*.MW,*NPHAP=,'6FX@D M1.Q(,SY%/QT.1S/4[W=(]S.A<\8_W5\7Z:Z29!.?#@9/3T^'E#WB)\8?XL. MK;LE.$EPLHV+U(YV1]F?-/Q=%-*'4_G7#,<$B>-%X]-=')[U9+Y9MD_'AXPO M!Z.CH^'@7Q]O)L&*K'$_I/*X!:271\E43''#DY.3@=J;2VO*W8Q'>1['@]Q. MD;+8&S;H2T[B\#16]FY8@!-5[:W9(% A_]?/97VYJ3\<]8^'A[MXWLL/OCJ" MG$7DGBR0*N9I\KP1*,6A)*&7;5MQLC";B3@?R/@!)4N=MDSJC07.)ZIA+=Q?XGQ M1F0P&@Y(E,3YEK[;I!^EASX-7W"V[F0C.W*L@_A;-"O2 M3P^UL 4I"+C)&9;'I 7U72Y-%V/:N9P'8D(.6PCM/]ITOM%R1!;("5$7Z7T MO^\&^Z1?0Q2?,7G&C$9'QT?'"I+[]^/I-Y67&->M&56YW6&NAE-'AV(<-11M M_62%.?E(UC/"M>*](MX&1*\NEH3JQ<'.(7NM8S-TYRA0J8CK!I', =I@CAYE M2NC'-"VT$=7.\*# M,"9W/ R$:#@\_.FH'=RWR<<:X&]YF(H3X2TR\>.$><.2Z2=6GA5*&-IDF2%Q M/9Z>1;*9-Y]Z1&2+<((P123+&VUDYC+D1Y7_]SL9O_=X8XIG^^$O]@E'L!3A='((]1SD(%5$.63JG=(NC>[)A MO FAJLPV.2:3.C!EC5><&(R!>*1:E(H=4O'/+>8)X=%S*Q@UI6TV *LZ'IK, M*T+,WD!("KE[3J8<4*8 Z^5"GT[FF9K$@4 MR;=?,&UO6$QBV\3 AG5FZDJOJ 'M@=RH")2%^(7.Y:,ZP(TDJ#,DXAS257KYIX:BFM$T08%5G1Y-Y18W9&\A+*D=*[P"9-"YP82S:89D4SD(2!59VUX"+5K.*[".,!1ZN=*;-,?Q[1H;4,"VM5! MJ0F]@@5R!P*3!N3VE"1>F>@7&PY MKSB'>Q]8:@N5-K,Y*Y#."UA:S-5>\4KE%5@<]D:7- F39SFSY'9K>$O+++'% M!V0NYT+?[P4/@"F=@U2&I ZE0F>UGS]5H(F,1#49C M !%[K9IAY8R*"]%*<1Q=TSG9_4Z>P;+5=':Y &Q6P=!$'I%A=@:@D8F14B,A M=P;''0_7F#]/PJ"EVZ@+[>(!&:WRH:L\ @2P!A"2J='D^L)UKS+%N^NY #9< MA.E,R1920+U=8%IL5[D!Q![AT^P0H$@$H6J4:YBN:<#XAI5>E[A@6]$8/E^P M.3QB:8FR"U:G(E3Q:@SQ"+(N/@'4*J$'Z3LMB,E9[BH!)%-P1MWY?"X.5IS] M"(RG?>YER(GV,^94^F%[Y! MI1-LZE:-T.QE_B%3\]8&C R0XQL9XAH5-=@:\SO.'D,:P,-H2.X$&L"TD1Q- MZQ\^9H-M#!6#Y#S.-4C98+WU9,EE;EJ;JDES4Y-J_ .E:JRUD4G5KK&X8W&" MH_^$F\:+=+/8"2)&PT90*DK_<#'9:X,FC4$BR-5%=X:M? !BG*ZF[;?VE-ID MJW@T7=[I!0@F1[6'T-G=E53DHJHEJYQ@H&6H[K96T09313V7]OE1S75#M5I6 MY[?0N#JAY1J)T=V*4?CE@KK$5FU#YO(:U_=[4>N *;WFE0PIG<,[]W*MMMC< ME)?V6>OI=3M%QY[O\**&=3>U;CO?[Z!&O_ P$;G+97FV-'LR9'H'$=#9JNE& MFWFM&T5>$-#DK+:N4:I%5;$#-"8L"H,P">GRH[@XY2$VESU@$K(1E5-D"H<%BSH)!X@4.L"^=B%N&,BE*M:Y6RJH8-A1) MVV\+ J.MO/HK.[VH>).C6B-0J6^'S?_E+E@)8P28[&"6V>X&3";UKJ"L\0*# M!F.UBY5,BG*MJ\D.^RYLV3XH6#H;%"Q;!@5+'P<%RZZ#@J7304&>=;I,B6BC MQK,H7&)@T<1&M6TP&BSKC!BD7N$"^P/;CB($[6-"F2>0%)TW.:DMNI@OAE<1(JEVPL9V'"9FGAJY"BFD0XJA8 MNM%T][P]Q!HQ'"HF\D:4FE8OL9B$;A?AM/%;??T)8XO)(I^I^R) M3@B.&27S]'Z+Z>E2L][N6S*5?_P0+ M"*FT2 T;SQ;:A(/.+!Y O@ M04E1KG7&P^6:\*7H[G[C["E996O(@N4#U';Y:+1K@ )E]8@M8P.:%;CIJ;S"1K(7(V8B 3R?LPM2]"4H4\Q0O3=%Q^)24(Y(2+=+1.YYB;,&H26_]B"FBX]MV4FM(+F%KMP=]0 M*2)0'N* G+%@F9>O\901^7U <"9%>X@MBKJ:SUEJTWM!5$>3.EKF_XE3X(K[[Y'H^W22Q[ M5&$.OF/>&&3Y442' F@/)!HB/,*O@TWHX82*1"KT *7!J!3M\+HMWJ].2.;O MG^_)@G YIV%*=LE[D=E#PY5'AUC;5W6=BZ-?Y+4&>@'B2]U"EX Q*B> 9O(] MLRP)]%4F@E0JIN^TES?=B%]B<[Y)_#7#,1%;_@]02P,$% @ )X5C5'7= M/7!B" L60 !4 !R8F]T+3(P,C(P,S S7W!R92YX;6S575USVS86?=^9 M_0^L^JQ/-^W&C;=C*W9'TR12+379[DL&(B$)8PA0 ="6_OT"%*E((@%>MJ-)/BIM7O]%H1%;%,F%C>M'Z;MF^GP]&H M%6E#1$*X%/2F)63KIW__\Q^1_??FFW8[>F"4)]?16QFW1V(A?XP^D#6]CGZF M@BIBI/HQ^DAXZCZ1#XQ3%0WE>L.IH?:+?MM>_F]?_ UGXNG:_9@3 M32.KE]#76\UN6J[=O-F7JXY4R^Z@U^MW__/^W31>T35I,^%TBVFK*.5JJ2K7 M?_WZ=3?[MH"6D-NYXD4;5]TBG$/-]EL6P!]%HMFUSL)[)V-B,MMKFXF\"/=; MNX"UW4?M_J!]U>]L==(JQ,\45)+31[J(W/_6O4.KSRPFBLDTV1 M-M2LW$K1Q4U+S:6QU0\&O:O>E:O\VQ.0V6ULS]3,=:Q6U#UI>*.HIL)D7-_9 M#TZ*T*VQ_8DF146N?7!HAAF'SKM+/VJ[OI6N;6/V<(_,(REBX3(^:9X[#^09 MUZ(_9TIK&G>6\KF;4&85'_3_^,X=MO>'F1#VU\]98[=S;12)35$;)W/*LS8^ M6\P9I/N7(UL0/<\Z0JK;2T(V67A=RHTN/LFB;/?Z>7_X-O_XLSOCJ)-I1N;. MKU*X.? <=Q[SL;.WZC1^HN*B8GMX8FNY%^>([H8H6U\[7C%^Z!$+)=<^$?,& M93!JJ1*J[-C:ZS5$=7L2T)$]U #EC[#(ZGO4#5MP%'YNPZ Q-@PYT7J\F!H9 M/]UN&<2-[\6ROKYW]K:7(6IL0E4VZ>AUW^9Q0-5U9@N_I>O[E&GNDO*OCLBKJ##F, M"5_)"G^'*CRXG%.I$_V=#GTB2A%A]$Q.4A6O[)QN+&C6_'AQ'N8]B5>WYGY+ M5.%E6:WL& 8K;1U6WDA:FO&^ICA7;.)%J5#Y! M8E]@+A.[@B3B:/%(E\PE4BZ< X_P\.$I@CWH7S2@!&DCVG$K1$KX(]U(5>/" M*1(H_G>-$+^*)*+FOZ9$&:KX#B)["0Q4_E4CE/=0Q9RMV"F89DXLB/IE-%#^ M[QLAOX\LHO[3%>7JNCBWXL$*OT!"DZZ&J3\&4]$W1^8 MC@G?1_5@/ZNZ%7X4?@4.P%#]<1/A&JX(Z@]3I4X" M"@X^?C14?]P4N(XM@@'WPC"S<^M2/J2>F]465D9!!<=->WWLT(0N;GX(X];> MA,0^1T(%Q\UV0RS11!_:H!7A(Y'0[2]T%U*]!(7*CIOE!GFBZ3Y1;$W4;LKB M^K&EC(4JCYO;AIFB23\CVU%B0V<+ME_D5N^ MPC4"-S$%L0;S8^1B*7:R*.[ MWD.9VK-U-Y1)\#)04Q#J#6[&>X$&: [=)HG53N?_.3;]D"^5#; M( \&EWDP@'N FPG7\FV0!U>7>7 %]P W&Z[EB^W!T!Z.U4R^>![)>\%0_7&S MX1JNV.IG',9JHN0SV^\_>T=X0X^AJ\ M0!!W*#[G@Z#I)\6,C<*M/T]%?@_)\S#0 X5JC9N !GDBZ#Z5G,7,,+%\;Z-7 MC/!JT:MP4,5QTTT_0P2Y)XHZZZF=XF>KX]P>8#5>+'RC=0@/E1\WVZQGC&_# M2.N4JDO-J"@%M00W\82RQQB.:)S:$7+7'\QG;I.[9S JH:#"XR:=/G8(0G^0 M,T72$.'??;>$7$ MDOH7>E0CH6KCYIHAEJCC]1(T7B\O'*]Q[$&U!QXH5'WDK;(AGABZIPDS--F']< $ M$;'-Y0Y4/#<+ZDM!W4#>2PMDC_;LXA/E_!CQA;<(U)(F M/$>MX8WFQT?)4RN9RE;A*L_9X8%"]6_"\U,/3[Q%K_NUYH=KUOXM?R'Y?26@ M+C3A06J8->+R/T/=&]/8,WU+#,FC#)GA*P$UHPD/5<.L43<[J*%EL93A%05G M0*CT35B07,D13?'IFG!^EVH;M@X.06= J.)-6'EV7UX]L-_Q&+2A @U^S443//"RQ7RS2QR[=2?[ MZ8!(B/)8$,)#36C&!EL_8P0;QF9%U?&,+ O(40BM#ZDO!;4$-V&&LL>[.!^] M"2)X;3[!0<5O0FI M392,*77/A_3A7 1D8< *H/XT(4.^2!.\NQ=?WO^9O>)3CU.3_0T&&V/P'D:P M'-2G)B3/$ 40YU3ZRVX^FMSM'NF"*K>08T:WYLXV]A2>8@&*0\UJQKNMP'I4 M>/:F6R)HFWRRW^;?N!_N[TO83_X'4$L! A0#% @ )X5C5)T-;4&L% MF7 !D ( ! &5A,34V-#(X+3AK7W9I8V%R:6]U#DY+3%?=FEC87)I;W5S+FAT;5!+ 0(4 Q0 ( ">% M8U0/B)P<^@, #\/ 1 " =LR !R8F]T+3(P,C(P,S S M+GAS9%!+ 0(4 Q0 ( ">%8U068H)((0D !EJ 5 " M 00W !R8F]T+3(P,C(P,S S7V1E9BYX;6Q02P$"% ,4 " GA6-4?>^K M[38, VD@ %0 @ %80 &UL4$L! A0#% @ )X5C5'7=/7!B" L60 !4 ( ! MP4P ')B;W0M,C R,C S,#-?<')E+GAM;%!+!08 !@ & )D! !650 " ! end